# NextPoint Therapeutics, Inc. — Form D

NextPoint Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-30. The offering totals $48.7M, of which $33.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-07-30
- Form: D
- Accession: 0001959209-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $48.7M
- Amount sold: $33.7M
- Remaining: $15.0M
- Investors: 15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-592689

## Issuer

- Name: NextPoint Therapeutics, Inc.
- CIK: 0001959209
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 238 MAIN STREET 238 Main Street, CAMBRIDGE, MA, 02142
- Phone: 508-204-1115

## Officers, directors & promoters (20)

| Name | Role | Location |
| --- | --- | --- |
| Detlev Biniszkiewicz | Related Person | Cambridge, MA |
| Ivan Cheung | Related Person | Cambridge, MA |
| Rakhshita Dhar | Related Person | Cambridge, MA |
| Paulina Hill | Related Person | Cambridge, MA |
| Axel Hoos | Related Person | Cambridge, MA |
| Jeffrey Lacey | Related Person | Cambridge, MA |
| Brian Shuster | Related Person | Cambridge, MA |
| R. Jacob Vogelstein | Related Person | Cambridge, MA |
| R. Jacob Vogelstein | Director | Cambridge, MA |
| Ansbert Gadicke | Director | Morristown, NJ |
| Axel Hoos | Director | Cambridge, MA |
| Paulina Hill | Director | Cambridge, MA |
| Matthew Roden | Director | Boston, MA |
| Matthew Roden) | Director | Cambridge, MA |
| Ivan Cheung | Director | Cambridge, MA |
| Ivan Cheung | Executive Officer | Cambridge, MA |
| Detlev Biniszkiewicz | Director | Cambridge, MA |
| Detlev Biniszkiewicz | Executive Officer | Cambridge, MA |
| Rakhshita Dhar | Director | Cambridge, MA |
| Paul Conrad | Executive Officer | Cambridge, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-02-14](https://search.stillhousedata.com/formd/0001959209-24-000001) | D | $42.5M | $42.5M |
| [2022-12-27](https://search.stillhousedata.com/formd/0001959209-22-000001) | D | $80.0M | $80.0M |

## More

- [CIK 1959209 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1959209&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001959209-26-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.